Cargando…
Principles of tumorigenesis and emerging molecular drivers of SHH‐activated medulloblastomas
SHH‐activated medulloblastomas (SHH‐MB) account for 25–30% of all medulloblastomas (MB) and occur with a bimodal age distribution, encompassing many infant and adult, but fewer childhood cases. Different age groups are characterized by distinct survival outcomes and age‐specific alterations of regul...
Autores principales: | Menyhárt, Otília, Győrffy, Balázs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529984/ https://www.ncbi.nlm.nih.gov/pubmed/31139698 http://dx.doi.org/10.1002/acn3.762 |
Ejemplares similares
-
Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas
por: Menyhárt, Otília, et al.
Publicado: (2019) -
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
por: Menyhárt, Otília, et al.
Publicado: (2020) -
Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis
por: Menyhárt, Otília, et al.
Publicado: (2021) -
The transcriptional landscape of Shh medulloblastoma
por: Skowron, Patryk, et al.
Publicado: (2021) -
Evasion of cell senescence in SHH medulloblastoma
por: Tamayo-Orrego, Lukas, et al.
Publicado: (2016)